930 results on '"Teisman A"'
Search Results
52. JNJ-67569762, A 2-Aminotetrahydropyridine-Based Selective BACE1 Inhibitor Targeting the S3 Pocket: From Discovery to Clinical Candidate
53. Governance of sustainability at airports: Moving beyond the debate between growth and noise
54. In vitro assessments of drug-induced delayed cardiotoxicity using human stem cell-derived cardiomyocytes
55. Impact of enforced and normal social housing on stress level and cardiovascular response in rat telemetry study
56. Fatal attraction: Exploring the potential value of “attractors” to identify new arrhythmic biomarkers in safety pharmacology
57. Detecting drug-induced delayed cardiac effects using human stem cell-derived cardiomyocytes
58. The Concordance between Nonclinical and Phase I Clinical Cardiovascular Assessment from a Cross-Company Data Sharing Initiative
59. Seizure-induced Torsades de pointes:In a canine drug-induced long-QT1 model
60. The resting membrane potential of hSC-CM in a syncytium is more hyperpolarised than that of isolated cells
61. Tools for professional practice to facilitate business model development and market adoption of improved bioP2methane technology
62. Over de boeg van een akkoord
63. The resting membrane potential of hSC-CM in a syncytium is more hyperpolarised than that of isolated cells
64. An integrated translational analysis summary: Prediction of HERG, isolated wedge preparation, anaesthetized guinea pig and dog towards phase I clinical data for drugs with different QT/TdP risk categories
65. A translational analysis: Cardiac ion channels and isolated rabbit left ventricular wedge in predicting CV safety risk
66. A translational research approach for cardiovascular safety assessment at Janssen
67. A translational analysis: In vitro hiPSC cardiomyocytes to human phase I analysis for a set of reference compounds with different QT/TdP risk categories
68. Translational research: What can we learn from the predictability of anesthetized guinea-pig and dog models for cardiovascular safety findings in man?
69. Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective
70. Effectief sturen met multi-level governance:Snel en slim schakelen tussen schalen
71. Choice of cardiac tissue plays an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit
72. Employing complexity: complexification management for locked issues
73. The effect of changes in core body temperature on the QT interval in beagle dogs: a previously ignored phenomenon, with a method for correction
74. Leadership and complexity: can individuals make differences in complex systems?
75. Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose
76. Assessing Drug-Induced Long QT and Proarrhythmic Risk Using Human Stem-Cell-Derived Cardiomyocytes in a Ca2+ Imaging Assay: Evaluation of 28 CiPA Compounds at Three Test Sites
77. Abstracts of papers and posters Pharmacological Meeting
78. Abstracts of papers and posters
79. Use of microdialysis for monitoring sympathetic and parasympathetic innervation of heart in conscious rats
80. Increase in dopamine release from the nucleus accumbens in response to feeding: a model to study interactions between drugs and naturally activated dopaminergic neurons in the rat brain
81. Employing Complexity: Complexification Management for Locked Issues
82. Employing complexity:complexification management for locked issues
83. Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes
84. Duurzame innovatie in industriële clusters
85. Overheden niet goed in innovatie?
86. DETERMINATION OF VOLATILE COMPONENTS IN CHEESE USING DYNAMIC HEADSPACE TECHNIQUES
87. Wanneer vele handen het werk niet lichter maken: Een complexiteitsbenadering voor gezinnen en instanties met multiproblematiek
88. Eb en vloed van het Deltaprogramma: De Deltacommunity anno 2019 in beeld gebracht
89. Leadership and complexity: Can individuals make differences in complex systems
90. Wanneer vele handen het werk niet lichter maken
91. Crystal Structure of BACE1 in complex with N-{3-[(4S,6S)-2-amino-4-methyl-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide
92. Employing complexity: complexification management for locked issues
93. Effectief sturen met multi-level governance: Snel en slim schakelen tussen schalen
94. Development of a Human iPSC Cardiomyocyte-Based Scoring System for Cardiac Hazard Identification in Early Drug Safety De-risking
95. Pharmacological Profile of the Sodium Current in Human Stem Cell-Derived Cardiomyocytes Compares to Heterologous Nav1.5+β1 Model
96. Trifluoromethyl Dihydrothiazine‐Based β‐Secretase (BACE1) Inhibitors with Robust Central β‐Amyloid Reduction and Minimal Covalent Binding Burden
97. Crystal Structure of BACE1 in complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide
98. Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose
99. Assessing Drug-Induced Long QT and Proarrhythmic Risk Using Human Stem-Cell-Derived Cardiomyocytes in a Ca2+ Imaging Assay: Evaluation of 28 CiPA Compounds at Three Test Sites
100. PPPs: torn between two lovers: like the star-crossed experiment in Utrecht in the 1990s discussed in this article, PPPs may be doomed to fail. They mix two value patterns and organisational principles that cannot easily be combined. New management strategies are required to cross the 'borders'
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.